Bloomberg Businessweek
Transcription
Bloomberg Businessweek
April 1 — April 7, 2013 | businessweek.com Samsung’s Secret How did the company that makes everything win at smartphones? Size—and the paranoia of Chairman Lee Kun Hee p58 Bloomberg Businessweek Contents Opening Remarks April 1 — April 7, 2013 Bloomberg Businessweek Handling it Hardworking attachés p78 10 Bitcoin, the anarchist virtual currency, may just be the global economy’s last safe haven Bloomberg View What the EU must do in Cyprus; gay marriage and the power of public opinion p12 Global Economics 15 Companies & Industries 23 Stumped at the gas pump Despite a U.S. oil boom, gas prices are still high— partly because refiners are boosting exports The cost of cost-cutting After trimming store staff, Walmart is having trouble stocking its shelves, angering customers Saudi land shortage The rise of the wearable machines p24 China is lovely for L’Oréal p25 p26 Is the Fed counting its money right? p17 p18 The U.S. shadow economy p19 Tom Keene’s EconoChat p19 Sunset for the Sun’s Page 3 girls? The week ahead p20 Briefs: Dell’s job insecurity p27 Politics & Policy 29 Technology 35 The Pac-Man sequester Phil Gramm’s efforts in the 1980s to force better budgeting may hold lessons for today All huffy at AOL The company bet $315 million on Arianna Huffington’s distinctive brand. Is it paying off? A break on student loans p30 China’s Internet originators p36 Obama’s green land grab p30 Amazon’s pilot season p37 Rand Paul woos Dad’s fans p31 DIY drones p38 Chris Christie: Outearned Innovator: Adieu, passwordsp39 by his wife and cool with it p32 Charlie Rose talks to Yahoo! A dim policy on headlights p33 teen tycoon Nick D’Aloisio p40 Markets & Finance Health Care 42 51 A $25 billion beating Brazilian billionaire Eike Batista is having a very bad year as stocks in his companies slide Prescription nannies Companies are trying an array of high-tech solutions to get patients to take their meds What M&A boom? Obamacare scare: Double-digit premium hikes? p52 p43 The troubling return of CDOs and their ilk p44 The crashing carbon marketp46 Bid&Ask: Picasso’s Le Rêvep47 Anti-Apple Samsung’s Galaxy models now outsell iPhones p58 Features 58 The Samsung Era How the South Korean conglomerate became the No. 1 smartphone maker—and its plans to stay on top p58 Screwed in Cyprus With the €10 billion bailout deal, Europe’s leaders say they’ve averted yet another crisis. Cypriots on the street don’t see it that way p66 Fall Guy or Crook? A Chinese functionary is charged with embezzling $14.5 million from the government. His story shows how insidious corruption is among low-level officials in China p70 Etc. 75 YouTube, the Star Maker A new breed of musical outliers is parlaying fame on the site into mainstream success Fashion The brief on briefcases p78 FAQ Will sponsors like Tiger Woods more? Is Lindsey Vonn aware of his past? Everything you wanted to know about the new sports power couple p80 Branding What Lululemon’s inadvertent transparency reveals p81 A Chinese startup takes aim at market leader Cochlear p53 Conspicuous Consumption The HBO series Game of Thrones beats any business book at illuminating corporate power struggles p82 Doubts about a promising Parkinson’s treatment p54 Hard Choices Michael Graves on ending his partnership with Target and following Ron Johnson to J.C. Penney p84 cover: thomas traum; this page, from top: bobby doherty; michael nagle/bloomberg 5 Page 32 April 1 — April 7, 2013 Bloomberg Businessweek A ● Abe, Shinzo 19 ABI Research 24 Adcock Ingram Holdings (AIP:SJ) 47 Aetna (AET) 52 Affiris 54 Agassi, Andre 80 Air France-KLM (AF:FP) 27 Akamai Technologies (AKAMI) 39 Alekstra 58 Aleph Objects 38 Alnylam Pharmaceuticals (ALNY) 54 Alwazir, Mohammad 17 Alzumaie, Mohammed 17 Amazon.com (AMZN) 23, 37, 42 American Express (AXP) 75 American Residential Properties 47 Amtrak 27 Anastasiades, Nicos 66 Anderson, Chris 38 Angelo Gordon 32 AOL(AOL) 35 47 Gramm, Phil 29 L’Oréal (LRLCY) Chang Sea-Jin 58 Graves, Michael 84 Lululemon Athletica (LULU) 81 Parsons 17 Cheil Worldwide 58 Grupo BTG Pactual Lyne, Susan 35 Paul, Rand 31 Christie, Chris 32 (BBTG11:BZ) 42 Macklemore 75 Paul, Ron 31 Christie, Mary Pat 32 Haier (1169:HK) 58 Mad Decent 75 PayPal (EBAY) 39 Hammer, Jan 75 Mahone, Austin 75 80 Malas, Stavros 66 Perakis-Valat, Alexis 25 Petrobras (PZE) 42 Phillips 66 (PSX) 15 Pimco 10 Poe, Ted 38 Popdust 75 Citigroup (C) 15, 19, 43, 44 25 Clark, Duncan 36 Hamm, Mia Claybrook, Joan 33 Hangzhou Nurotron ClimateCare 46 Biotechnology 53 Marc by Marc Jacobs 78 Cluttons 17 Hanrahan, Edward 46 Marks, Craig 75 CNBC (CMCSA) 52 Harada, Cesar 38 Mars 27 Coach (COH) 78 Harding, Nathan 24 Martin, George R.R. 82 Cochlear (COH:AU) 53 Harris (HRS) 39 Marvel Comics (DIS) 24 Marathon Petroleum (MPC) 15 Cohen, Steven 47 Maymann, Jimmy 35 ConAgra (CAG) 20 Heckman, James 18 May-Treanor, Misty 80 Conant, Douglas 82 H. Lundbeck 47 Mayweather, Floyd 80 HBO (TWX) 35, 82 Costco Wholesale (COST) 23 Home Depot (HD) McConnell, Mitch 31 Cowell, Simon 75 Huang, Guangyu 70 McCoy Solar 30 CSM (CSM:NA) 47 Huawei (002502:CH) 58 McNamee, Roger 37 CVS Caremark (CVS) 51 Huffington, Arianna 35 MediSafe Project 51 Hyatt Hotels (H) 35 Mendham Capital Mgmt. 32 Cyprus Popular Bank (CPB:CY) 66 ●●● 23, 27 I J K D E F ●●● Mercedes-Benz (DAI) 33 Merkel, Angela 66 Miami Heat 75 Parker, Jim 82 PricewaterhouseCoopers 52 TNK-BP 47 Primus, Wendel 29 Toyota Motor (TM) 58 75 Treanor, Matt 80 Prince Procter & Gamble (PG) 25, 58 Trudeau, Garry 37 38 Tumblr 26 Proteus Digital Health 51 Twitter 10, 26 Psy 75 Protei ●●● 80 Qiming Venture Partners 53 27, 43 Mintel Group 25 Rhodes, William 19 52 Mizrahi, Isaac 84 Rhone Capital 47 42 Moe, Jeff 38 Riff Raff 75 Argo Medical Technologies 24 De Juniac, Alexandre 27 Innovation Works 36 Moelis 43 Rihanna 75 Instagram 10 Mohan, Dominic 26 Roberts, Chris 53 36 Monsanto (MON) 20, 38 Dell, Michael 27 Intel Capital (INTC) Rolex 80 Audi (VOW:GR) 33 Del Rey, Lana 75 Interscope Records (VIVHY) 75 Morgan Stanley (MS) 43 Rosneft (ROSN:LI) 47 Australian Broadcasting 53 Denters, Esmée 75 Ireland, Peter 18 Morse, Ed 15 Rousseff, Dilma 42 De Oliveira, Luma 42 IronFX 66 MPX Energia (MPXE3:BZ) 42 RWE (RWE:GR) 46 ● 51 Van Eck Associates 42 47 Vassiliou, George 66 Safeway (SWY) 23 Verizon Communications (VZ) 43 Salazar, Ken 30 Verizon Wireless 27 Vickers Capital 36 Johnson, Ron 84 27, 84 N O ●● Nakamoto, Satoshi 10 Bank of Cyprus (BOCY:CY) 66 Dooney & Bourke 78 JPMorgan Chase (JPM)32, 44, 47 Bank of Japan (8301:JP) 20 Driscoll, James 18 Karmali, Abyd 46 National Commercial Bank 17 Duke Energy (DUK) 30 Kennedy, Anthony 12 Nestlé (NESN:VX) 27 37 36 37 Bell Potter Securities 53 Ben Minkoff 78 Benton, Jesse 31 Berkshire Hathaway (BRK.A) 43 Bertolini, Mark 52 Best Buy (BBY) 27 Bezos, Jeff 37, 42 Bidvest Group (BVT:SJ) 47 Bieber, Justin 75 Billy Reid 78 Bitcoin 10 BlackBerry (BBRY) 58 Blackstone Group (BX) 27, 43, 47 Blair, Tony 46 BMW (BMW:GR) 33 Boeing (BA) 38 Bono 32 BP (BP) 47 Brown, Sherrod 44 Buffett, Warren 43 Burker King (BKW) 10 Bush, George W. 30 BuzzFeed 10 C ● Campbell Soup (CPB) 82 EBay (EBAY) 10 Kesanupalli, Ramesh 39 Netflix (NFLX) EBX Group 42 Kimbra 75 NeuroPhage Pharmaceuticals 54 Eclat Textile (1476:TT) 81 King Abdullah 17 Newman, Mark 58 EClinicalWorks 51 King, David 46 News Corp. (NWS) 26 Economic Outlook Group 19 Klesse, Bill 15 Next Big Sound 75 EDF Renewable 30 Kohl’s (KSS) 23 Nokia (NOK) 58 Ekso Bionics 24 Kuroda, Haruhiko 19 Nok Nok Labs 39 Elan (ELN) 54 Kuzcma, Ed 42 Nordegren, Elin 80 Emirates 27 Esteves, André 42 Euromonitor International 25 ExxonMobil (XOM) 46 Facebook (FB) 10, 26, 66, 80, 81 25 Face Shop (973:HK) Northrop Grumman (NOC) 38 ●● NXP Semiconductors (NXPI) 39 L M Obama, Barack Ginsburg, Ruth Bader 12 24 Goldman Sachs (GS) 43 32 Google China (GOOG) 36 Carlsberg (CARLA:DC) 46 Google (GOOG) Carr, Bill 37 10, 35, 58 Gosar, Paul 38 Cazenove Capital Holdings 47 Gotye 75 CBRE Group (CBG) Graf, Steffi 80 47 Short, Clare 26 Silver Lake Management 27 Simon, Bill 23 Sina (SINA) 36 Skype (MSFT) 75 Spinetta, Jean-Cyril 27 Springsteen, Bruce 25 Goffer, Amit Shire (SHPG) 70 L’Occitane (COC:GR) 17 36 Ouyang, Changqing 43 Ghosheh, Adnan 36 75 Sequoia Capital 82 70 80 44 47 Seacrest, Ryan Southwest Airlines (LUV) Li Huabo Genworth Financial Warren, Elizabeth WeChat Schroders (SDR:LN) 47 Life Technologies (LIFE) 58 58 Otsuka Holdings 54 33 Walt Disney (DIS) 58 Fox, Michael J. 38 15 58 40 General Motors (GM) 23 Schork, Stephen Sony (SNE) Li Ka-shing 38 Wal-Mart Stores (WMT) 42 32 General Electric (GE) Walgreen (WAG) 15 OSX Brasil (OSXB3:BZ) Fleet Securities General Dynamics (GD) 47 Schork Group 42 53 General Atomics 23 ● P 44 SARcode Bioscience 39 Li Fangping 58 80 (OGXP3:BZ) 78 80 43 Vonn, Lindsey Onset Ventures 44 Gartner (IT) Vodafone Group (VOD) 58 Sanford C. Bernstein (AB) 58 58 Fisher, Richard 51 Samsung Life Insurance Lee, Keon-Hyok 39, 58 Vitality Vitter, David 58 Filson + Apolis Garciaparra, Nomar 58 36 Lenovo (0992:HK) ●● OGX Petróleo e Gás (005930:KS) Samsung Heavy Industries 58 Lee, DJ Lee, Kun-Hee G H 30, 46 Samsung Electronics Lee, Kai-Fu 18 Fayyad, Salam Cantor Fitzgerald 17 78 39 SAC Capital Advisors 82 Begley Jr., Ed Valextra Validity Sensors RxAnte Dinklage, Peter BDA China 42 75 75 42 15 Vale (VALE) 26 Jepsen, Carly Rae 42 Valero Energy (VLO) Murdoch, Rupert J.C. Penney (JCP) Batista, Thor 36 MTV (VIA) 12 Batista, Eike 75 Uucun 75 Dijsselbloem, Jeroen 18 75 Usher 24 Deutsche Lufthansa (LHA:GR) 27 44 Upton, Kate Jasinski, Larry 78 Barnett, William 75 Island Def Jam 43 75 Barofsky, Neil (VIVHY) Universal Republic Records 75 Deutsche Bank (DB) Bally 43, 46 Universal Music Group DeStefano-Orebaugh, Lisa 27 Baauer Bank of America (BAC) ●●● U V W Q R S ING (ING) B 46 25 Ignagni, Karen 27, 51 38 Tillerson, Rex Tmall 39 AT&T (T) 3D Robotics T-Mobile USA (DTE:GR) 27, 80 37 44 27, 43, 47 Tencent Holdings (TCEHY) 36 Price, Roy Daniel Tarullo Dell (DELL) 38 Prana Biotechnology (PRAN) 54 DCM 35 39 Teal Group 75 Mickelson, Phil Icahn, Carl 23, 84 Tata 35 39, 58 40 Target (TGT) Time Warner (TWX) IBM (IBM) D’Aloisio, Nick T ● Timberlake, Justin Apple (AAPL)10, 27, 40, 58, 84 Armstrong, Tim 6 CBS (CBS) Weibo 36 Woods, Tiger 80 Wynn, Steve 47 ●●● x yz Xi Jinping 19, 36 Xu Chaojun 36 Xu Detang 70 32 Yahoo! (YHOO) 40 Stewart, Martha 82 Youku (YOKU) Strategy Analytics 58 YouTube (GOOG) 36 36, 75 PaPa 36 Strickland, David 33 Zeng, Fan-Gang 53 Lockheed Martin (LMT) 24, 38 Paris Presents 19 Summly 40 Zhang Zhendong 36 Lofgren, Zoe Parker Hannifin (PH) 24 Syson, Kristian 17 ZTE (000063:CH) 58 38 How to Contact Bloomberg Businessweek Editorial 212-617-6231 Ad Sales 212-617-2900 Subscriptions 800-635-1200 Address 731 Lexington Ave., New York, NY 10022 E-mail [email protected] Fax 212-617-9065 Subscription Service PO Box 37528, Boone, IA 50037-0528 E-mail [email protected] Reprints/Permissions 800-290-5460 x100 or [email protected] Letters to the Editor can be sent by e-mail, fax, or regular mail. They should include address, phone number(s), and e-mail address if available. Connections with the subject of the letter should be disclosed, and we reserve the right to edit for sense, style, and space. from left: timothy a. clary/afp/getty images; charlie neibergall/ap photo; hassan ammar/ap photo Index Page 17 Page 29 A Chinese Hearing Implant Takes Aim at Cochlear - Businessweek 9 of 14 http://www.businessweek.com/articles/2013-03-28/a-chinese-hearing-im... Will Hillary Clinton Run for President in 2016? Iron Man Meets HULC: Suit with Super-Human Strength Myanmar Offers Rich Potential: Maersk Michigan's Right-To-Work Law: Bottom Line (3/28) Illustration by Joe Magee Devices A Chinese Hearing Implant Takes Aim at Cochlear By Bruce Einhorn and Natasha Khan on March 28, 2013 Tweet Facebook LinkedIn Google Plus 2 Comments Email 3/30/2013 6:14 PM A Chinese Hearing Implant Takes Aim at Cochlear - Businessweek 10 of 14 http://www.businessweek.com/articles/2013-03-28/a-chinese-hearing-im... Print Special Report Focus On Health Care, March 2013 'Take Your Pills' Reminders From Apps and Gadgets Pharma Pipelines, by the Numbers Obamacare Scare: Double-Digit Premium Hikes? A Setback on the Road to a Parkinson's Cure Companies Mentioned COH Cochlear Ltd $68.05 AUD -0.35 -0.51% Market data is delayed at least 15 minutes. Company Lookup After suddenly going deaf at age 30, Ke Liu, a civil servant in China’s eastern Jiangxi province, didn’t have many options. A cochlear implant might’ve restored his hearing, but the imported device cost tens of thousands of dollars. In 2010, Ke learned about a clinical trial for an implant made by a Chinese company, Hangzhou Nurotron Biotechnology. That year he had one surgically implanted and has since recovered nearly all of his hearing. “I have my old life back,” says the 38-year-old. Unlike hearing aides, which simply amplify sound, cochlear implants translate soundwaves into signals sent directly to the brain. Nurotron has received approval from China’s health regulators to sell its implant on the mainland. At 98,000 yuan ($16,000), the price of its devices is less than half that of imported implants, says Nisa Leung, a board member who is a partner at Qiming Ventures Partners, a venture capital firm and an investor in Nurotron. That price gap threatens companies that dominate the estimated $1 billion market for cochlear implants. The leader is Australia’s Cochlear (COH), which sold more than $600 million of the devices in its 2012 fiscal year ended June. Cochlear has enjoyed “a virtual monopoly,” says Stuart Roberts, an analyst with Bell Potter Securities in Sydney. He notes the price of cochlear implants has barely budged over the years, while other sophisticated electronics—such as computer chips—have gotten less expensive even as quality has improved. That’s what motivated Fan-Gang Zeng to try to come up with a cheaper alternative. The Chinese native, who has a Ph.D. in hearing science from Syracuse University, is director of the Center for Hearing Research at the University of California at Irvine. Zeng, who launched Nurotron in 2005, says finding researchers to work on his project was not a problem. “Cochlear made a lot of enemies along the way,” Zeng says of the company’s pricing. “So when we asked for help, we got help.” Cochlear declined to be interviewed for this story. Nurotron also got plenty of assistance in China, where there are 28 million deaf people and 30,000 babies born without hearing each year. The government, the Chinese Academy of Sciences, and state-backed hospitals contributed about 75 percent of the startup’s initial funding of 30 million yuan (about $3.7 million at the time), Zeng says. Mainland authorities were also willing to fast-track the approval process, which usually takes three to five years. After wrapping up clinical trials in 2010, Nurotron secured permission in less than a year to have its cochlear implants used in patients aged six and older. If low-cost options such as Nurotron’s make cochlear implants as popular in China as they are in the U.S., “we are talking about 100,000 devices a year,” says Zeng, who now heads development at Nurotron. The company is focused on basics, such as building a sales team and training Chinese doctors to perform the operation. It’s also contemplating expanding into Latin America, according to Li Fangping, a former real estate developer who’s now the company’s president. Zeng says Nurotron will “eventually” consider applying for approval in the U.S. and hopes the U.S. Food and Drug Administration will accept data from the Chinese trials. In India, government-backed researchers are starting clinical trials of a locally developed device, says Dr. J.M. Hans, chairman of the ENT and cochlear implant department at the Rockland Group of Hospitals in the New Delhi area. It will take “another two years before trials are done and we are sure the thing works,” says Hans. If it does, a made-in-India implant could cost as little as $2,500. Cochlear’s Sydney-listed shares are down 13.5 percent this year, compared with a 7.4 percent increase for Australia’s benchmark index, amid sluggish sales in the U.S., Europe, and developed Asia. “China offers a huge opportunity,” Chief Executive Officer Chris Roberts told the Australian Broadcasting Corp. on Feb. 10. But only if Cochlear has a solution for the local competition. Nurotron’s Li says his company’s low-cost manufacturing base gives it an edge over its Australian rival. “The raw materials for our products are the same,” he says. “The difference is, if it costs us 3,000 yuan per worker, it might cost them $3,000 per worker.” The bottom line: A Chinese startup threatens to upend the $1 billion market for cochlear implants with a low-cost alternative. Einhorn is Asia regional editor in Bloomberg Businessweek's Hong Kong bureau. Khan is a reporter for Bloomberg News in Hong Kong. Tweet 3/30/2013 6:14 PM A Chinese Hearing Implant Takes Aim at Cochlear - Businessweek 11 of 14 http://www.businessweek.com/articles/2013-03-28/a-chinese-hearing-im... Facebook LinkedIn Google Plus 2 Comments Email Print by Taboola by Taboola 2 comments Best 0 Community O_Pinion • Share 2 days ago Interesting to note that Chinese authorities were able to grant this company an approval in 12 months when it would usually takes 3-5 years. What does that tell you about how local companies are "favored" by the Chinese government. While it would be a step too far to say this is evidence of corruption it does indicate that the Chinese regulatory regime has a long way to go before it can be classed as robust and independent. 0 • Reply • Share › James LaCroix O_Pinion • 3 hours ago Any other government would do the same. 0 • Reply • Share › What's this? ALSO ON BUSINESSWEEK.COM Expensify Brings Bitcoin to Main Street Coming to a City Near You: Chinese Business Incubators 5 comments • 2 days ago 5 comments • 23 days ago BitSpend — You can also spend your Bitcoins anywhere you want, using https://bitspend.net. So while Bitcoins may not be accepted at all retailers yet, Bitspend makes it possible for you to buy ANYTHING and pay with Bitcoins. (yeah, it's a shameless Taishanese — We need more cross border investments from China. One thing we need to keep in mind, is that as China increases her investments in the US, she still has a ways to go to catch up with Japan's cumulative investments in the US of over $300 billion. And a Apple, Volkswagen Face the Wrath of Chinese Media 3 comments • 3 days ago yi xiong — china just did what it should do, protect domestic companies, and you are brainless to believe all the American media are unbiased. Feed Most Popular Read Shared Discussed 3/30/2013 6:14 PM